{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:01:54Z","timestamp":1781766114952,"version":"3.54.5"},"reference-count":12,"publisher":"The Pediatric Pharmacy Association","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"abstract":"<jats:sec>\n          <jats:title>OBJECTIVE<\/jats:title>\n          <jats:p>Therapeutic hypothermia reduces the risk of death and major disability in neonates with moderate-to-severe hypoxic ischemic encephalopathy (HIE). Opioids and benzodiazepines are used to manage agitation but contribute to hemodynamic and respiratory instability. The objective of this study was to evaluate the safety and efficacy of dexmedetomidine (DEX) compared with fentanyl (FENT) in neonates with HIE undergoing therapeutic hypothermia.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>METHODS<\/jats:title>\n          <jats:p>This was a retrospective, single-center study comparing outcomes in neonates with HIE undergoing therapeutic hypothermia who received FENT to those who received DEX.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>RESULTS<\/jats:title>\n          <jats:p>A total of 45 neonates were included (FENT, n = 19; DEX, n = 26). The DEX group had a decreased need for sedative bolus doses during therapeutic hypothermia compared with the FENT group; however, there was no difference in number of uncontrolled agitation scores or need for additional scheduled sedatives. The DEX group had a shorter time to discontinuation of sedatives after rewarming compared with the FENT group (0.52 versus 5 days, respectively; p = 0.001), shorter time to extubation after birth (3.1 versus 11.3 days, respectively; p = 0.004), and earlier time to resumption of feeds (8.5 versus 13 days, respectively; p = 0.03). A non-statistically significant reduction in seizures was noted (3 versus 7 subjects, respectively; p = 0.07). There was no difference in baseline characteristics, mortality, or adverse effects.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>CONCLUSIONS<\/jats:title>\n          <jats:p>The use of DEX during therapeutic hypothermia for HIE appears to provide comparable control of agitation to FENT with a reduced need for additional sedatives and may lead to an earlier time to extubation and discontinuation of sedatives.<\/jats:p>\n        <\/jats:sec>","DOI":"10.5863\/1551-6776-27.4.352","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T19:17:17Z","timestamp":1652123837000},"page":"352-357","source":"Crossref","is-referenced-by-count":7,"title":["Dexmedetomidine Versus Fentanyl for Neonates With Hypoxic Ischemic Encephalopathy Undergoing Therapeutic Hypothermia"],"prefix":"10.5863","volume":"27","author":[{"given":"Maryam","family":"Naveed","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University of Chicago Medicine Comer Children's Hospital, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah S.","family":"Bondi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Chicago Medicine Comer Children's Hospital, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja A.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Chicago Medicine Comer Children's Hospital, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","reference":[{"issue":"4","key":"i2331-348X-27-4-352-b1","series-title":"JAMA Pediatr","first-page":"397","article-title":"Hypoxic-ischemic encephalopathy: a review for the clinician","volume":"169","year":"2015","unstructured":"Douglas-Escobar\n              M,\n            \n            \n              Weiss\n              MD.\n            \n          \n          Hypoxic-ischemic encephalopathy: a review for the clinician.\n\t\t\t\t\tJAMA Pediatr.\n\t\t\t\t\t2015;\n\t\t\t\t\t169(\n\t\t\t\t\t4):\n\t\t\t\t\t397\u2013\n\t\t\t\t\t403."},{"issue":"3","key":"i2331-348X-27-4-352-b2","series-title":"Newborn Infant Nurs Rev","first-page":"125","article-title":"Hypoxic ischemic encephalopathy: pathophysiology and experimental treatments","volume":"11","year":"2011","unstructured":"Allen\n              KA,\n            \n            \n              Brandon\n              DH.\n            \n          \n          Hypoxic ischemic encephalopathy: pathophysiology and experimental treatments.\n\t\t\t\t\tNewborn Infant Nurs Rev.\n\t\t\t\t\t2011;\n\t\t\t\t\t11(\n\t\t\t\t\t3):\n\t\t\t\t\t125\u2013\n\t\t\t\t\t133."},{"issue":"6","key":"i2331-348X-27-4-352-b3","series-title":"Curr Treat Options Neurol","first-page":"608","article-title":"Therapeutic hypothermia for neonatal encephalopathy","volume":"14","year":"2012","unstructured":"Shankaran\n              S.\n            \n          \n          Therapeutic hypothermia for neonatal encephalopathy.\n\t\t\t\t\tCurr Treat Options Neurol.\n\t\t\t\t\t2012;\n\t\t\t\t\t14(\n\t\t\t\t\t6):\n\t\t\t\t\t608\u2013\n\t\t\t\t\t619."},{"issue":"6","key":"i2331-348X-27-4-352-b4","series-title":"Arch Pediatr Adolesc Med","first-page":"558","article-title":"Hypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis","volume":"166","year":"2012","unstructured":"Tagin\n              MA,\n            \n            \n              Woolcott\n              CG,\n            \n            \n              Vincer\n              MJ,\n            \n          \n          .\n\t\t\t\t\tHypothermia for neonatal hypoxic ischemic encephalopathy: an updated systematic review and meta-analysis.\n\t\t\t\t\tArch Pediatr Adolesc Med.\n\t\t\t\t\t2012;\n\t\t\t\t\t166(\n\t\t\t\t\t6):\n\t\t\t\t\t558\u2013\n\t\t\t\t\t566."},{"issue":"2","key":"i2331-348X-27-4-352-b5","series-title":"Curr Neurol Neurosci Rep","first-page":"2","article-title":"Therapeutic hypothermia in neonatal hypoxic-ischemic encephalopathy","volume":"19","year":"2019","unstructured":"Wassink\n              G,\n            \n            \n              Davidson\n              JO,\n            \n            \n              Dhillon\n              SK,\n            \n          \n          .\n\t\t\t\t\tTherapeutic hypothermia in neonatal hypoxic-ischemic encephalopathy.\n\t\t\t\t\tCurr Neurol Neurosci Rep.\n\t\t\t\t\t2019;\n\t\t\t\t\t19(\n\t\t\t\t\t2):\n\t\t\t\t\t2."},{"issue":"8","key":"i2331-348X-27-4-352-b6","series-title":"Semin Perinatol","first-page":"549","article-title":"Outcomes in childhood following therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy (HIE)","volume":"40","year":"2016","unstructured":"Natarajan\n              G,\n            \n            \n              Pappas\n              A,\n            \n            \n              Shankaran\n              S.\n            \n          \n          Outcomes in childhood following therapeutic hypothermia for neonatal hypoxic-ischemic encephalopathy (HIE).\n\t\t\t\t\tSemin Perinatol.\n\t\t\t\t\t2016;\n\t\t\t\t\t40(\n\t\t\t\t\t8):\n\t\t\t\t\t549\u2013\n\t\t\t\t\t555."},{"issue":"3","key":"i2331-348X-27-4-352-b7","series-title":"Pediatr Res","first-page":"405","article-title":"Twenty-four hours of mild hypothermia in unsedated newborn pigs starting after a severe global hypoxic-ischemic insult is not neuroprotective","volume":"50","year":"2001","unstructured":"Thoresen\n              M,\n            \n            \n              Satas\n              S,\n            \n            \n              L\u00f8berg\n              EM,\n            \n          \n          .\n\t\t\t\t\tTwenty-four hours of mild hypothermia in unsedated newborn pigs starting after a severe global hypoxic-ischemic insult is not neuroprotective.\n\t\t\t\t\tPediatr Res.\n\t\t\t\t\t2001;\n\t\t\t\t\t50(\n\t\t\t\t\t3):\n\t\t\t\t\t405\u2013\n\t\t\t\t\t411."},{"issue":"1","key":"i2331-348X-27-4-352-b8","series-title":"J Perinatol","first-page":"79","article-title":"Opioid and benzodiazepine use during therapeutic hypothermia in encephalopathic neonates","volume":"40","year":"2020","unstructured":"Berube\n              MW,\n            \n            \n              Lemmon\n              ME,\n            \n            \n              Pizoli\n              CE,\n            \n          \n          .\n\t\t\t\t\tOpioid and benzodiazepine use during therapeutic hypothermia in encephalopathic neonates.\n\t\t\t\t\tJ Perinatol.\n\t\t\t\t\t2020;\n\t\t\t\t\t40(\n\t\t\t\t\t1):\n\t\t\t\t\t79\u2013\n\t\t\t\t\t88."},{"issue":"3","key":"i2331-348X-27-4-352-b9","series-title":"AJP Rep","first-page":"e168","article-title":"Dexmedetomidine for sedation of neonates with HIE undergoing therapeutic hypothermia: a single-center experience","volume":"8","year":"2018","unstructured":"O'Mara\n              K,\n            \n            \n              Weiss\n              MD.\n            \n          \n          Dexmedetomidine for sedation of neonates with HIE undergoing therapeutic hypothermia: a single-center experience.\n\t\t\t\t\tAJP Rep.\n\t\t\t\t\t2018;\n\t\t\t\t\t8(\n\t\t\t\t\t3):\n\t\t\t\t\te168\u2013\n\t\t\t\t\te173."},{"issue":"9","key":"i2331-348X-27-4-352-b10","series-title":"J Perinatol","first-page":"2284","article-title":"Dexmedetomidine versus intermittent morphine for sedation of neonates with encephalopathy undergoing therapeutic hypothermia","volume":"41","year":"2021","unstructured":"Cosnahan\n              AS,\n            \n            \n              Angert\n              RM,\n            \n            \n              Jano\n              E,\n            \n            \n              Wachtel\n              EV.\n            \n          \n          Dexmedetomidine versus intermittent morphine for sedation of neonates with encephalopathy undergoing therapeutic hypothermia.\n\t\t\t\t\tJ Perinatol.\n\t\t\t\t\t2021;\n\t\t\t\t\t41(\n\t\t\t\t\t9):\n\t\t\t\t\t2284\u2013\n\t\t\t\t\t2291."},{"issue":"1","key":"i2331-348X-27-4-352-b11","series-title":"Pediatr Anesth Crit Care J","first-page":"22","article-title":"Is dexmedetomidine a potential neuroprotective agent for term neonates with hypoxic-ischemic encephalopathy?","volume":"7","year":"2019","unstructured":"Surkov\n              D.\n            \n          \n          Is dexmedetomidine a potential neuroprotective agent for term neonates with hypoxic-ischemic encephalopathy?\n          \n            Pediatr Anesth Crit Care J\n          .\n\t\t\t\t\t2019;\n\t\t\t\t\t7(\n\t\t\t\t\t1):\n\t\t\t\t\t22\u2013\n\t\t\t\t\t30."},{"key":"i2331-348X-27-4-352-b12","series-title":"Drug Des Devel Ther","first-page":"4439","article-title":"Dexmedetomidine promotes hippocampal neurogenesis and improves spatial learning and memory in neonatal rats","volume":"13","year":"2019","unstructured":"Zhang\n              Y,\n            \n            \n              Gao\n              Q,\n            \n            \n              Wu\n              Z,\n            \n          \n          .\n\t\t\t\t\tDexmedetomidine promotes hippocampal neurogenesis and improves spatial learning and memory in neonatal rats.\n\t\t\t\t\tDrug Des Devel Ther.\n\t\t\t\t\t2019;\n\t\t\t\t\t13:\n\t\t\t\t\t4439\u2013\n\t\t\t\t\t4449."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/27\/4\/article-p352.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/27\/4\/352\/3060068\/i2331-348x-27-4-352.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/27\/4\/article-p352.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/27\/4\/article-p352.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:34:37Z","timestamp":1747355677000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/27\/4\/article-p352.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":12,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-27.4.352","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"value":"2331-348X","type":"electronic"},{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}